ConductScience.org, home

Paper33643288

Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.

Koopman JJE and 4 others. Front Immunol, 2020. Cited by 66 papers, by iCite.

Cite this record

ConductScience Library. Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys. Papers, record 33643288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33643288

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.
PubMed
Journal
Front Immunol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
4.94
iCite
Revised in PubMed
2024-03-31
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Koopman JJEJacob J E
2van Essen MFMieke F
3Rennke HGHelmut G
4de Vries APJAiko P J
5van Kooten CCees

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement Inactivating AgentsMajor topic
Complement Membrane Attack ComplexMajor topic
KidneyMajor topic
Kidney DiseasesMajor topic
Humans

References226

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132345771PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma.Aging (Albany NY)2020https://conductscience.org/library/papers/32345771PubMed
227472742Complement activation and effect of eculizumab in scleroderma renal crisis.Medicine (Baltimore)2016https://conductscience.org/library/papers/27472742PubMed
321057849Membranoproliferative pattern of glomerular injury associated with complement component 9 deficiency due to Arg95Stop mutation.Clin Exp Nephrol2011https://conductscience.org/library/papers/21057849PubMed
430655025Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis.Kidney Int2019https://conductscience.org/library/papers/30655025PubMed
524924752Eculizumab treatment for rescue of renal function in IgA nephropathy.Pediatr Nephrol2014https://conductscience.org/library/papers/24924752PubMed
629725633Complement Activation in Patients With Diabetic Nephropathy.Kidney Int Rep2018https://conductscience.org/library/papers/29725633PubMed
72415178Monoclonal antibodies against neoantigens of the terminal C5b-9 complex of human complement.Biosci Rep1985https://conductscience.org/library/papers/2415178PubMed
812717204Complement activation in early protocol kidney graft biopsies after living-donor transplantation.Transplantation2003https://conductscience.org/library/papers/12717204PubMed
91720203Detection of polymorphonuclear cells, superoxide dismutase and poly C9 in glomeruli of patients with IgA nephropathy.Nephron1991https://conductscience.org/library/papers/1720203PubMed
1031229026Terminal complement effectors in atypical hemolytic uremic syndrome: C5a, C5b-9, or a bit of both?Kidney Int2019https://conductscience.org/library/papers/31229026PubMed
1128736435Extracellular vesicles in renal disease.Nat Rev Nephrol2017https://conductscience.org/library/papers/28736435PubMed
1228819100Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy.Sci Rep2017https://conductscience.org/library/papers/28819100PubMed
132467771Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.Clin Exp Immunol1989https://conductscience.org/library/papers/2467771PubMed
147607624Role of complement in renal tubular damage.Histopathology1995https://conductscience.org/library/papers/7607624PubMed
1531787968Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics.Front Immunol2019https://conductscience.org/library/papers/31787968PubMed
169063527Immunohistochemistry of complement response on human renal cell carcinoma biopsies.Tumori1996https://conductscience.org/library/papers/9063527PubMed
1730929519Role of Complement-Related Inflammation and Vascular Dysfunction in Hypertension.Hypertension2019https://conductscience.org/library/papers/30929519PubMed
183548335Ultrastructural localization of the membrane attack complex of complement in human renal tissues.Am J Kidney Dis1987https://conductscience.org/library/papers/3548335PubMed
1930429287Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.J Immunol2018https://conductscience.org/library/papers/30429287PubMed
201944729Homozygous C3 deficiency associated with IgA nephropathy.Nephron1991https://conductscience.org/library/papers/1944729PubMed

See all 226 referencesDownload CSV of references

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
42948706Correlation of Glomerular MBL Deposition with the Clinicopathology and Prognosis of Idiopathic Membranous Nephropathy: A PLA2R Subgroup Analysis.Int J Gen Med2026https://conductscience.org/library/papers/42948706PubMed
42939591Complement-Metabolic Inflammation Crosstalk: Molecular Mechanisms and Therapeutic Targets in Type 2 Diabetes and Its Complications.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42939591PubMed
42852122Complement biomarkers in IgA nephropathy: current insights and clinical relevance.Front Nephrol2026https://conductscience.org/library/papers/42852122PubMed
42553762Programmed Cell Death: A Key Mechanism of Traditional Chinese Medicine in the Treatment of Membranous Nephropathy.Drug Des Devel Ther2026https://conductscience.org/library/papers/42553762PubMed
42548161Clinicopathological features and outcomes of glomerular microangiopathy: a retrospective cohort study.Ren Fail2026https://conductscience.org/library/papers/42548161PubMed
42469261Internalized components of membrane attack complexes disrupt proteostasis and acquire alarmin-like properties.Nat Commun2026https://conductscience.org/library/papers/42469261PubMed
42427641Internalized Components of Membrane Attack Complexes Disrupt Proteostasis and Acquire Alarmin-Like Properties.bioRxiv2026https://conductscience.org/library/papers/42427641PubMed
42292840Tubulointerstitial inflammation and fibrosis induced by proteinuria: fresh insights.Front Pharmacol2026https://conductscience.org/library/papers/42292840PubMed
42106625Comparison of the efficacy of obinutuzumab versus rituximab combined with tacrolimus in the treatment of refractory membranous nephropathy.BMC Nephrol2026https://conductscience.org/library/papers/42106625PubMed
41872605The endothelium response to kidney injury.Nat Rev Nephrol2026https://conductscience.org/library/papers/41872605PubMed
41813685Design of miniprotein inhibitors targeting complement C9 to block membrane attack complex assembly.Nat Commun2026https://conductscience.org/library/papers/41813685PubMed
41807808Global research trends and hotspots in targeted therapy for IgA nephropathy: a bibliometric and visualization analysis (1999-2025).Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41807808PubMed
41714421Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy.Pediatr Nephrol2026https://conductscience.org/library/papers/41714421PubMed
41608159Advances in Complement-Targeted Therapy for IgA Nephropathy.Kidney Dis (Basel)2026https://conductscience.org/library/papers/41608159PubMed
41591175The Pathological Role of LDL in Membranous Nephropathy and Diabetic Nephropathy and the Protective Efficacy of LDL Apheresis: A Narrative Review.Toxins (Basel)2026https://conductscience.org/library/papers/41591175PubMed
41404698Biomarkers in the Management of Complement-Mediated Kidney Diseases in the Era of Complement Therapeutics.Clin J Am Soc Nephrol2026https://conductscience.org/library/papers/41404698PubMed
41375892The Role of Complement Activation in Diabetic Nephropathy: Current Insights and Future Directions.J Clin Med2025https://conductscience.org/library/papers/41375892PubMed
41347971Update in the diagnosis of complement-mediated thrombotic microangiopathy/atypical hemolytic uremic syndrome.Hematology Am Soc Hematol Educ Program2025https://conductscience.org/library/papers/41347971PubMed
41272252Establishment of a Time-Resolved Fluoroimmunoassay for sC5b-9 and Validation in Lupus Nephritis.J Fluoresc2026https://conductscience.org/library/papers/41272252PubMed
41215783Alternative pathway-mediated tubular complement activation in human proteinuric kidney diseases: a proof-of-concept study.Clin Kidney J2025https://conductscience.org/library/papers/41215783PubMed

See all 57 cited byDownload CSV of cited by

Genes24

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABO28PubTator's text mininghttps://conductscience.org/library/genes/28NCBI Gene
C1QA712PubTator's text mininghttps://conductscience.org/library/genes/712NCBI Gene
C5727PubTator's text mininghttps://conductscience.org/library/genes/727NCBI Gene
C5AR1728PubTator's text mininghttps://conductscience.org/library/genes/728NCBI Gene
CD551604PubTator's text mininghttps://conductscience.org/library/genes/1604NCBI Gene
CD59966PubTator's text mininghttps://conductscience.org/library/genes/966NCBI Gene
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
CFB629PubTator's text mininghttps://conductscience.org/library/genes/629NCBI Gene
CFD1675PubTator's text mininghttps://conductscience.org/library/genes/1675NCBI Gene
CFH3075PubTator's text mininghttps://conductscience.org/library/genes/3075NCBI Gene
CFHR581494PubTator's text mininghttps://conductscience.org/library/genes/81494NCBI Gene
CFP5199PubTator's text mininghttps://conductscience.org/library/genes/5199NCBI Gene
CLU1191PubTator's text mininghttps://conductscience.org/library/genes/1191NCBI Gene
CR11378PubTator's text mininghttps://conductscience.org/library/genes/1378NCBI Gene
ERVK-13100861467PubTator's text mininghttps://conductscience.org/library/genes/100861467NCBI Gene
HBE13046PubTator's text mininghttps://conductscience.org/library/genes/3046NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
IGHA13493PubTator's text mininghttps://conductscience.org/library/genes/3493NCBI Gene
MASP15648PubTator's text mininghttps://conductscience.org/library/genes/5648NCBI Gene
MBL24153PubTator's text mininghttps://conductscience.org/library/genes/4153NCBI Gene

See all 24 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33643288

GET https://conductscience.org/api/papers/v1/33643288/references?page=2